BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35986402)

  • 21. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma.
    Jin L; Quan J; Pan X; He T; Hu J; Li Y; Gui Y; Yang S; Mao X; Chen Y; Lai Y
    Mol Med Rep; 2017 Nov; 16(5):7072-7079. PubMed ID: 28901455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
    Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
    Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
    Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
    Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
    Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
    Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
    Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
    Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A.
    Hu Z; Li L; Cheng P; Liu Q; Zheng X; Peng F; Zhang Q
    J Cell Biochem; 2020 Oct; 121(10):4085-4093. PubMed ID: 31916281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression pattern of long non-coding RNAs in renal cell carcinoma revealed by microarray.
    Qin C; Han Z; Qian J; Bao M; Li P; Ju X; Zhang S; Zhang L; Li S; Cao Q; Lu Q; Li J; Shao P; Meng X; Zhang W; Yin C
    PLoS One; 2014; 9(6):e99372. PubMed ID: 24905231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
    Zhang L; Wang C; Ma M
    Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
    Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
    Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
    Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L
    Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA Z38 promotes cell proliferation and metastasis in human renal cell carcinoma.
    He X; Liu H; Guo F; Feng Y; Gao Y; Sun F; Song B; Lu H; Li Y
    Mol Med Rep; 2017 Oct; 16(4):5489-5494. PubMed ID: 28849012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.